{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:12:56Z","timestamp":1783163576002,"version":"3.54.6"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270875"],"award-info":[{"award-number":["81270875"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471424"],"award-info":[{"award-number":["81471424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471029"],"award-info":[{"award-number":["81471029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12958-017-0227-8","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T13:09:35Z","timestamp":1485436175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients"],"prefix":"10.1186","volume":"15","author":[{"given":"Yu","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"key":"227_CR1","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","volume":"84","author":"E Diamanti-Kandarakis","year":"1999","unstructured":"Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocr Metab. 1999;84:4006\u201311.","journal-title":"J Clin Endocr Metab"},{"key":"227_CR2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0889-8529(05)70075-X","volume":"28","author":"RS Legro","year":"1999","unstructured":"Legro RS. Polycystic ovary syndrome. Phenotype to genotype. Endocrin Metab Clin. 1999;28:379\u201396.","journal-title":"Endocrin Metab Clin"},{"key":"227_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0020-7292(01)00477-5","volume":"75","author":"S Weerakiet","year":"2001","unstructured":"Weerakiet S, Srisombut C, Bunnag P, Sangtong S, Chuangsoongnoen N, Rojanasakul A. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome. Int J Obstet GY. 2001;75:177\u201384.","journal-title":"Int J Obstet GY"},{"key":"227_CR4","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774\u2013800.","journal-title":"Endocr Rev"},{"key":"227_CR5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","volume":"318","author":"M Brownlee","year":"1988","unstructured":"Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl J Med. 1988;318:1315\u201321.","journal-title":"New Engl J Med"},{"key":"227_CR6","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2011-3408","volume":"97","author":"C Piperi","year":"2012","unstructured":"Piperi C, Adamopoulos C, Dalagiorgou G, Diamanti-Kandarakis E, Papavassiliou AG. Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. J Clin Endocr Metab. 2012;97:2231\u201342.","journal-title":"J Clin Endocr Metab"},{"key":"227_CR7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","volume":"69","author":"E Diamanti-Kandarakis","year":"2008","unstructured":"Diamanti-Kandarakis E, Katsikis I, Piperi C, Kandaraki E, Piouka A, Papavassiliou AG, et al. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol. 2008;69:634\u201341.","journal-title":"Clin Endocrinol"},{"key":"227_CR8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/humrep\/det383","volume":"29","author":"Z Merhi","year":"2014","unstructured":"Merhi Z. Advanced glycation end products and their relevance in female reproduction. Hum Reprod. 2014;29:135\u201345.","journal-title":"Hum Reprod"},{"key":"227_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fertnstert.2012.11.029","volume":"99","author":"C Tatone","year":"2013","unstructured":"Tatone C, Amicarelli F. The aging ovary--the poor granulosa cells. Fertil Steril. 2013;99:12\u20137.","journal-title":"Fertil Steril"},{"key":"227_CR10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1573399052952631","volume":"1","author":"S Yamagishi","year":"2005","unstructured":"Yamagishi S, Nakamura K, Imaizumi T. Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev. 2005;1:93\u2013106.","journal-title":"Curr Diabetes Rev"},{"key":"227_CR11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/CS20080494","volume":"116","author":"AZ Kalea","year":"2009","unstructured":"Kalea AZ, Schmidt AM, Hudson BI. RAGE: a novel biological and genetic marker for vascular disease. Clin Sci. 2009;116:621\u201337.","journal-title":"Clin Sci"},{"key":"227_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","volume":"62","author":"E Diamanti-Kandarakis","year":"2005","unstructured":"Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol. 2005;62:37\u201343.","journal-title":"Clin Endocrinol"},{"key":"227_CR13","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1210\/jc.2005-2559","volume":"91","author":"G Basta","year":"2006","unstructured":"Basta G, Sironi AM, Lazzerini G, Del Turco S, Buzzigoli E, Casolaro A, et al. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. J Clin Endocr Metab. 2006;91:4628\u201334.","journal-title":"J Clin Endocr Metab"},{"key":"227_CR14","doi-asserted-by":"crossref","first-page":"E886","DOI":"10.1210\/jc.2013-4374","volume":"99","author":"M Irani","year":"2014","unstructured":"Irani M, Minkoff H, Seifer DB, Merhi Z. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. J Clin Endocr Metab. 2014;99:E886\u201390.","journal-title":"J Clin Endocr Metab"},{"key":"227_CR15","first-page":"19","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u201325.","journal-title":"Fertil Steril"},{"key":"227_CR16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-2006-924233","volume":"114","author":"Z Radikova","year":"2006","unstructured":"Radikova Z, Koska J, Huckova M, Ksinantova L, Imrich R, Vigas M, et al. Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocr Diab. 2006;114:249\u201356.","journal-title":"Exp Clin Endocr Diab"},{"key":"227_CR17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219\u201331.","journal-title":"Nat Rev Endocrinol"},{"key":"227_CR18","first-page":"2317","volume":"83","author":"R Azziz","year":"1998","unstructured":"Azziz R, Black V, Hines GA, Fox LM, Boots LR. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis. J Clin Endocr Metab. 1998;83:2317\u201323.","journal-title":"J Clin Endocr Metab"},{"key":"227_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.2003.01842.x","volume":"60","author":"T Tsilchorozidou","year":"2004","unstructured":"Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol. 2004;60:1\u201317.","journal-title":"Clin Endocrinol"},{"key":"227_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/ENDO:30:1:13","volume":"30","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E. Insulin resistance in PCOS. Endocrine. 2006;30:13\u20137.","journal-title":"Endocrine"},{"key":"227_CR21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.59566\/IJBS.2011.7191","volume":"7","author":"MN Amin","year":"2011","unstructured":"Amin MN, Mosa AA, EI-Shishtawy MM. Clinical study of advanced glycation end products in egyptian diabetic obese and non-obese patients. Int J Biomed Sci. 2011;7:191\u2013200.","journal-title":"Int J Biomed Sci"},{"key":"227_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2007.07.025","volume":"196","author":"G Basta","year":"2008","unstructured":"Basta G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis. 2008;196:9\u201321.","journal-title":"Atherosclerosis"},{"key":"227_CR23","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.metabol.2009.05.025","volume":"58","author":"P Boor","year":"2009","unstructured":"Boor P, Celec P, Behuliak M, Grancic P, Kebis A, Kukan M, et al. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats. Metabolism. 2009;58:1669\u201377.","journal-title":"Metabolism"},{"key":"227_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/815942","author":"LJN Jensen","year":"2015","unstructured":"Jensen LJN, Flyvbjerg A, Bjerre M. Souble receptor for advanced glycation end products: A biomarker for acute coronary syndrome. BioMed Res Int. 2015. doi: 10.1155\/2015\/815942 .","journal-title":"BioMed Res Int"},{"key":"227_CR25","doi-asserted-by":"crossref","unstructured":"Prasad K, Tiwari S. Therapeutic interventions for advanced glycation-end products and its receptor-mediated cardiovascular disease. Curr Pharm Des. 2016. Epub ahead of print.","DOI":"10.2174\/1381612822666161006143032"},{"key":"227_CR26","first-page":"1626","volume":"86","author":"R Azziz","year":"2001","unstructured":"Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocr Metab. 2001;86:1626\u201332.","journal-title":"J Clin Endocr Metab"},{"key":"227_CR27","doi-asserted-by":"crossref","first-page":"e36610","DOI":"10.1371\/journal.pone.0036610","volume":"7","author":"X Jia","year":"2012","unstructured":"Jia X, Chang T, Wilson TW, Wu L. Methylglyoxal mediates adipocyte proliferation by increasing phosphorylation of Akt1. PLoS One. 2012;7:e36610.","journal-title":"PLoS One"},{"key":"227_CR28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/MOL.0b013e32835aea13","volume":"24","author":"KH Gaens","year":"2013","unstructured":"Gaens KH, Stehouwer CD, Schalkwijk CG. Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity. Curr Opin Lipidol. 2013;24:4\u201311.","journal-title":"Curr Opin Lipidol"},{"key":"227_CR29","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","volume":"25","author":"H Koyama","year":"2005","unstructured":"Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscl Throm Vas. 2005;25:2587\u201393.","journal-title":"Arterioscl Throm Vas"},{"key":"227_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.numecd.2008.03.004","volume":"19","author":"GD Norata","year":"2009","unstructured":"Norata GD, Garlaschelli K, Grigore L, Tibolla G, Raselli S, Redaelli L, et al. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist\/hip ratio in the general population. Nutr Metab Cardiovas. 2009;19:129\u201334.","journal-title":"Nutr Metab Cardiovas"},{"key":"227_CR31","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2174\/138161208784139747","volume":"14","author":"H Unoki","year":"2008","unstructured":"Unoki H, Yamagishi S. Advanced glycation end products and insulin resistance. Curr Pharm Design. 2008;14:987\u20139.","journal-title":"Curr Pharm Design"},{"key":"227_CR32","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/01.CIR.0000039325.03698.36","volume":"106","author":"LG Bucciarelli","year":"2002","unstructured":"Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL, et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation. 2002;106:2827\u201335.","journal-title":"Circulation"},{"key":"227_CR33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","volume":"4","author":"L Park","year":"1998","unstructured":"Park L, Raman KG, Lee KJ, Lu Y, Ferran Jr LJ, Chow WS, et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products. Nat Med. 1998;4:1025\u201331.","journal-title":"Nat Med"},{"key":"227_CR34","first-page":"1025","volume":"44","author":"ID Nicholl","year":"1998","unstructured":"Nicholl ID, Bucala R. Advanced glycation end products and cigarette smoking. Cell Mol Biol. 1998;44:1025\u201333.","journal-title":"Cell Mol Biol"},{"key":"227_CR35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/10408398909527499","volume":"28","author":"J O\u2019Brien","year":"1989","unstructured":"O\u2019Brien J, Morrissey PA. Nutritional and toxicological aspects of the Maillard browning reaction in foods. Crit Rev Food Sci. 1989;28:211\u201348.","journal-title":"Crit Rev Food Sci"},{"key":"227_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF03401321","volume":"13","author":"E Tantalaki","year":"2014","unstructured":"Tantalaki E, Piperi C, Livadas S, Kollias A, Adamopoulos C, Koulouri A, et al. Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS). Hormones. 2014;13:65\u201373.","journal-title":"Hormones"},{"key":"227_CR37","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00109-007-0246-6","volume":"85","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, Kandaraki E, Levidou G, Papalois A, et al. Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J Mol Med. 2007;85:1413\u201320.","journal-title":"J Mol Med"},{"key":"227_CR38","doi-asserted-by":"crossref","first-page":"E1726","DOI":"10.1210\/jc.2012-1473","volume":"97","author":"N Vazzana","year":"2012","unstructured":"Vazzana N, Guagnano MT, Cuccurullo C, Ferrante E, Lattanzio S, Liani R, et al. Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress. J Clin Endocr Metab. 2012;97:E1726\u201330.","journal-title":"J Clin Endocr Metab"},{"key":"227_CR39","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ijo.2012.107","volume":"36","author":"JM Brix","year":"2012","unstructured":"Brix JM, H\u00f6llerl F, Kopp HP, Schernthaner GH, Schernthaner G. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity. Int J Obesity. 2012;36:1412\u20137.","journal-title":"Int J Obesity"},{"key":"227_CR40","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.fertnstert.2009.03.029","volume":"94","author":"EY Fujii","year":"2010","unstructured":"Fujii EY, Nakayama M. The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging. Fertil Steril. 2010;94:694\u2013700.","journal-title":"Fertil Steril"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-017-0227-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T02:38:23Z","timestamp":1719023903000},"score":1,"resource":{"primary":{"URL":"http:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-017-0227-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["227"],"URL":"https:\/\/doi.org\/10.1186\/s12958-017-0227-8","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,26]]},"article-number":"9"}}